- is indicated for the topical treatment of canine bacterial infections of the skin, including superficial pyoderma, caused by susceptible strains of Staphylococcus aureus and Staphylococcus intermedius.
CONTRAINDICATIONS: This drug is contraindicated in animals with a history of sensitivity reactions to any of its components.
WARNINGS: Because of the potential hazard of nephrotoxicity due to the polyethylene glycol content of the base, care should be exercised when using this product in treating extensive deep lesions where absorption of large quantities of polyethylene glycol is possible.
Safety of use in pregnant or breeding animals has not been determined.
Muricin® ointment is not for ophthalmic use.
Keep out of reach or children and pets.
ADVERSE REACTIONS: No adverse reactions have been reported with this product. If a skin reaction such as irritation should occur, treatment should be discontinued and appropriate therapy instituted.
Store between 15° and 30°C (59° and 86°F).
Each gram of Muricin® ointment contains 20 mg of mupirocin in a bland, water-washable ointment base consisting of polyethylene glycol 400 and polyethylene glycol 3350 (polyethylene glycol ointment, NF)